Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aeglea BioTherapeutics
Aeglea BioTherapeutics
Faced with rocky interim data for rare disease drug, Aeglea lays off more staff and seeks exit route
Fierce Biotech
Wed, 04/12/23 - 11:45 am
Aeglea BioTherapeutics
layoffs
pegtarviliase
Aeglea culls workers, shifts pipeline focus after knockback by FDA
Fierce Biotech
Wed, 08/24/22 - 10:39 am
Aeglea BioTherapeutics
FDA
layoffs
Another refuse-to-file for a small biotech — is the FDA using RTFs to manage its workload?
Endpoints
Thu, 06/2/22 - 07:24 pm
FDA
Aeglea BioTherapeutics
pegzilarginase
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Rare Diseases
Rare Disease Company Coalition
drug development
drug discovery
Acceleron
Aeglea BioTherapeutics
Agios Pharmaceuticals
Alnylam
Harmony Biosciences
Orchard Therapeutics
Orphazyme
Sarepta Therapeutics
Taysha Gene Therapies
Ultragenyx
Week Ahead: Small-Cap Biotech IPO Kicks-Off Q2
Seeking Alpha
Sat, 04/2/16 - 02:06 pm
biotech
IPOs
Aeglea BioTherapeutics